Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Radiopharmaceutical for chronic knee synovitis in development at British university

Nov. 11, 1998

European filing announced for Enbrel

Nov. 11, 1998

ATTRACT study establishes efficacy, safety of infliximab in RA patients

Nov. 11, 1998

Cevimeline improves symptoms of xerostomia in animal models, patients with Sjogren's syndrome

Nov. 10, 1998

Knoll's promising new treatment for RA covered in depth at rheumatology congress

Nov. 10, 1998

New series from Agouron with inhibitory activity against MMPs and TNF-alpha production

Nov. 10, 1998

Merck finally reveals chemical structure of lead COX-2 inhibitor

Nov. 6, 1998

Eisai to collaborate with Toyama in development, marketing of DMARD

Nov. 5, 1998

Inhibitors of cell adhesion with antiinflammatory activity developed at Japan Energy

Nov. 5, 1998

SmithKline Beecham describes new cannabinoid receptor agonists

Nov. 5, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...